Top compounds associated with response to CORO2B


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib CCLE pan-cancer AAC -0.15 0.001
mRNA CHIR-99021 GDSC1000 pan-cancer AAC 0.1 0.002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Erlotinib CCLE pan-cancer AAC -0.14 0.002
mRNA Vandetanib CCLE pan-cancer AAC -0.15 0.002
mRNA SNS-032 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA AG-014699 GDSC1000 pan-cancer AAC 0.1 0.003
mRNA AICAR GDSC1000 pan-cancer AAC 0.095 0.003
mRNA Erlotinib gCSI pan-cancer AAC -0.16 0.005
Download CSV